SCHEMBL17459261

SCHEMBL17459261

O=c1cccc(Oc2ncc(Cl)cn2)n1-c1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2B Q13224 2/20 0.40
CYP1A2 P05177 7/20 0.38
USP2 O75604 5/20 0.38
ALDH1A1 P00352 4/20 0.38
TSHR P16473 3/20 0.38
HSD17B10 Q99714 3/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
CYP3A4 P08684 5/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C19 P33261 3/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17459256 0.80 CYP1A2 (0.44) RXRAGRIN1GRIN2BCYP1A2CYP3A4
SCHEMBL17459254 0.79 RXRA (0.53) RXRAGRIN1GRIN2B
SCHEMBL17459258 0.75 SMN1; SMN2 (0.44) CYP1A2USP2ALDH1A1TSHRHSD17B10
SCHEMBL17459255 0.66 KMT2A (0.46) USP2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL30912185 0.63 SMN1; SMN2 (0.42) RXRAGRIN1GRIN2BCYP1A2TSHR
SCHEMBL11161634 0.62 MEN1 (0.57) CYP1A2USP2ALDH1A1TSHRHSD17B10
SCHEMBL9192280 0.61 L3MBTL1 (0.47) RXRAGRIN1GRIN2BCYP1A2ALDH1A1
SCHEMBL23629553 0.61 MAPK14 (0.41) CYP2C19MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL11392451 0.61 HDAC6 (0.47) CYP1A2ALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL9693794 0.60 MEN1 (0.70) CYP1A2ALDH1A1TSHRHSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963442-B2 Pyridones as herbicides E. I. DU PONT DE NEMOURS AND COMPANY (US) 2018-05-08 US claimed
US-20170204081-A1 PYRIDONES AS HERBICIDES E I DU PONT DE NEMOURS AND COMPANY (US) 2017-07-20 US claimed
EP-3171698-A1 PYRIDONES AS HERBICIDES E. I. du Pont de Nemours and Company (US) 2017-05-31 EP claimed
WO-2016014814-A1 PYRIDONES AS HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2016-01-28 WO claimed
US-9963442-B2 Pyridones as herbicides E. I. DU PONT DE NEMOURS AND COMPANY (US) 2018-05-08 US disclosed
US-20170204081-A1 PYRIDONES AS HERBICIDES E I DU PONT DE NEMOURS AND COMPANY (US) 2017-07-20 US disclosed
EP-3171698-A1 PYRIDONES AS HERBICIDES E. I. du Pont de Nemours and Company (US) 2017-05-31 EP disclosed
WO-2016014814-A1 PYRIDONES AS HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2016-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204081-A1 PYRIDONES AS HERBICIDES CYP1B1, PNPO, CYP1A1 RXRA 392/4885GRIN1 709/4885GRIN2B 1720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.